Nanoparticle Transfer Through Endothelial Barrier - NanoTENDO

Project summary

The controlled delivery of drugs to the brain remains a challenge in the effective treatment of neurodegenerative diseases due to the role played by the endothelial barrier. The endothelial barrier is an important part of the body. It consists of the layer of the special cells organized in a complex system. This barrier surrounds our vessels and protects the body tissues from unwanted visitors: microbes and toxic substances. However, the fact that this barrier recognizes all substances as intruding species causes a huge medical problem in treatment for many severe brain diseases, among them the Alzheimer disease. Our project aims to develop the nanoformulations based on dendrimers, dendrons or gold nanoparticles which will overcome the endothelial barrier resulting in the effective and specific delivery of therapeutic substances.

Project Details

Call

Call 2018


Call Topic

New strategies for advanced material-based technologies in health applications


Project start

01.10.2019


Project end

31.08.2024


Total project costs

600.854 €


Total project funding

600.854 €


TRL

1 - 3


Coordinator

Prof. Maria Bryszewska

University of Lodz, Department of General Biophysics, Narutowicza 68, 90-136 Lodz, Poland


Partners and Funders Details

Consortium Partner   Country Funder
University of Lodz, Department of General Biophysics
https://www.uni.lodz.pl
University Poland PL-NCN
Universidad de Alcala, Organic and Inorganic Chemistry
https://www.uah.es
University Spain No Funding
Riga Stradins University
https://www.rsu.lv
University Latvia LV-VIAA
Latvian Biomedical Research and Study Centre
http://bmc.biomed.lu.lv/en/
Research org. Latvia LV-VIAA

Keywords

biological barrier, nanoparticles, neurosciences, biological sciences, blood brain barrier